All news
TOGAS: Towards Gastric Cancer Screening Implementation in the European Union
17 April 2023On 30 – 31 March, DiCE participated in the kick-off meeting of the TOGAS project held in Riga, Latvia. TOGAS, which stands for TOwards GAstri...
Liver Cancer Index – The Mapping Survey Is Available Online
17 April 2023The survey was created to map the liver cancer treatment landscape across the EU and is now available online and disseminated among several relevan...
EuropaColon Slovenia Celebrates Its 15th Anniversary
17 April 2023This March EuropaColon Slovenia rang in its 15th anniversary as a patient association! EC Slovenia was an original member of EuropaColon, the Europ...
Primary Findings From The GLOW Study Signals Positive Momentum In The Development Of Novel Therapeutic Options For Patients With HER2-Negative Locally Advanced Unresectable Or Metastatic Gastric & GEJ Cancers
20 March 2023At the end of 2022, leaders of the Phase 3 clinical trial GLOW shared their positive primary findings. GLOW (NCT03653507) is a global, multicenter,...
Health Is Local – DiCE Members Organise National Policy Events
20 March 2023At DiCE, we aim to cover both European and national aspects of policymaking. That is why this year, we will be supporting DiCE Member Organisations...
Trastuzumab Deruxtecan Meets Objective Response Rate Endpoint in Several Types of HER2-expressing Advanced Solid Tumours
20 March 2023Positive topline results of the ongoing DESTINY-PanTumour02 Phase II trial (NCT04482309) showed that treatment with trastuzumab deruxtecan met the...
The First International Management Guidelines for Early-Onset Colorectal Cancer
20 March 2023This March, the Clinical Gastroenterology and Hepatology journal published the first management guidelines for Early-Onset Colorectal Cancer (eo-CR...
FAPA On It’s 30th Anniversary
17 March 2023The day was filled with informative talks, including an introduction from Prof. Dr Eric Van Cutsem for the Dutch-speaking audience of patients, out...
Imfinzi & Imjudo Immunotherapy Drug Combinations Approved in the EU for the Treatment of Advanced Liver Cancer
2 March 2023The combination of durvalumab (Imfinzi) and tremelimumab (Imjudo) immunotherapies has been approved by the European Commission (EC) for the first-l...
Zolbetuximab Plus Chemotherapy Extends Overall Survival for Patients with Advanced or Metastatic Gastric & Gastro-oesophageal Junction Adenocarcinoma
16 February 2023The Annual American Society of Clinical Oncologists Gastrointestinal Cancers Symposium (ASCO GI) kicked off the year with lots of new data in the f...
